These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20044807)

  • 1. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
    Moreno M; Gonzalo T; Kok RJ; Sancho-Bru P; van Beuge M; Swart J; Prakash J; Temming K; Fondevila C; Beljaars L; Lacombe M; van der Hoeven P; Arroyo V; Poelstra K; Brenner DA; Ginès P; Bataller R
    Hepatology; 2010 Mar; 51(3):942-52. PubMed ID: 20044807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
    Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
    PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.
    Colmenero J; Bataller R; Sancho-Bru P; Domínguez M; Moreno M; Forns X; Bruguera M; Arroyo V; Brenner DA; Ginès P
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G726-34. PubMed ID: 19628656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.
    Wei H; Lu H; Li D; Zhan Y; Wang Z; Huang X
    Chin Med J (Engl); 2001 Jun; 114(6):583-7. PubMed ID: 11780431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
    Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
    Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.
    Li S; Wang Q; Tao Y; Liu C
    J Pharmacol Exp Ther; 2016 Nov; 359(2):247-255. PubMed ID: 27543328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
    van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
    Greupink R; Bakker HI; Bouma W; Reker-Smit C; Meijer DK; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology.
    Gonzalo T; Talman EG; van de Ven A; Temming K; Greupink R; Beljaars L; Reker-Smit C; Meijer DK; Molema G; Poelstra K; Kok RJ
    J Control Release; 2006 Mar; 111(1-2):193-203. PubMed ID: 16466667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiotensin-1 receptor blockade in cirrhotic liver resection.
    Bahde R; Kebschull L; Stöppeler S; Zibert A; Siaj R; Hölzen JP; Minin E; Schmidt HH; Spiegel HU; Palmes D
    Liver Int; 2011 May; 31(5):642-55. PubMed ID: 21457437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
    van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
    Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
    J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers.
    Hagens WI; Beljaars L; Mann DA; Wright MC; Julien B; Lotersztajn S; Reker-Smit C; Poelstra K
    J Pharmacol Exp Ther; 2008 Mar; 324(3):902-10. PubMed ID: 18077624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
    Wei YH; Jun L; Qiang CJ
    Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
    Parreira NA; Ramalho FS; Augusto MJ; Silva DM; Prado CM; Elias Júnior J; Rodrigues V; Ramalho LNZ
    Exp Parasitol; 2018 Aug; 191():9-18. PubMed ID: 29890165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.